(EMAILWIRE.COM, July 27, 2019 ) Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market.

The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6%.

Market Dynamics

+ Drivers

+ Growing Awareness About Vitamin D Deficiency Among Consumers
+ Presence of A Large Target Patient Population

Request for Free Sample Pages - https://www.marketsandmarkets.com/requestsampleNew.asp?id=32540026

The oral route of administration is expected to register the largest share and highest CAGR during the forecast period. This can be attributed to the ease of administration, better pharmacokinetic and pharmacodynamic activity, reduced chance of toxicity, increased patient compliance, and higher preference for the oral route.

The market is segmented into osteoporosis, rickets, skin diseases, muscle weakness, autoimmune disorders, and other applications. The osteoporosis segment is expected to register the highest growth during the forecast period. This growth can be attributed to the increasing incidence of falls and fractures in senior adults due to the elevated levels of parathyroid hormones and the poor absorption of calcium from their diets.

View Complete Press Releases - https://www.marketsandmarkets.com/PressReleases/vitamin-d-therapy.asp